http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190041606-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a726ac9558a84d8a1b01841d2102e3d |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-12 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2017-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c426a5431200445159d0909dc6bc1913 |
| publicationDate | 2019-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20190041606-A |
| titleOfInvention | A method of detecting wheezing of pediatric respiratory infections using eosinophil-derived neurotoxin |
| abstract | The present invention relates to a method for determining wheezing of respiratory infections. The present invention analyzes the significant correlation between eosinophil-derived neurotoxin (EDN) levels and wheezing (wheezing) in patients with respiratory infections, and suggests that EDN can be used in pediatric patients suffering from or suffering from respiratory tract infections It can be used as a marking marker for the occurrence or recurrence of wheezing. Therefore, by objectifying the level of EDN, it is possible to observe the wheat through more effective and accurate discrimination, so that it can be effectively applied to the development of preventive and remedial drugs that can be continuously managed. |
| priorityDate | 2017-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 160.